STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
23.30
-0.22 (-0.94%)
Sep 2, 2026, 12:03 PM EDT - Market open
STAAR Surgical Company Income Statement
Financials in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 3, 2026 | Jan '26 Jan 2, 2026 | Dec '24 Dec 27, 2024 | Dec '23 Dec 29, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 31, 2021 |
| 339.59 | 239.44 | 313.9 | 322.42 | 284.39 | 230.47 | |
Revenue Growth | 51.30% | -23.72% | -2.64% | 13.37% | 23.39% | 41.00% |
Cost of Revenue | 79.39 | 57.02 | 74.32 | 69.76 | 61.01 | 51.84 |
Gross Profit | 260.2 | 182.42 | 239.58 | 252.65 | 223.38 | 178.64 |
Selling, General & Admin | 180.62 | 188.1 | 206.61 | 182.47 | 143.1 | 111.54 |
Research & Development | 38.32 | 40.06 | 45.32 | 40.48 | 35.98 | 33.86 |
Operating Expenses | 218.94 | 228.16 | 251.93 | 222.94 | 179.08 | 145.4 |
Operating Income | 41.26 | -45.74 | -12.35 | 29.71 | 44.3 | 33.24 |
Interest Expense | - | - | - | - | - | -0.04 |
Interest & Investment Income | 3.71 | 4.59 | 5.91 | 6.99 | 2.45 | - |
Currency Exchange Gain (Loss) | -2.9 | 2.6 | -3.68 | -1.91 | -1.71 | -2.96 |
Other Non Operating Income (Expenses) | 2.59 | 2.05 | 1.06 | 0.3 | 0.81 | 1.07 |
EBT Excluding Unusual Items | 44.66 | -36.5 | -9.05 | 35.09 | 45.85 | 31.3 |
Merger & Restructuring Charges | -26.47 | -30.36 | - | - | - | - |
Asset Writedown | -0.81 | -15.4 | - | - | - | - |
Other Unusual Items | - | - | - | -1.39 | -0.3 | - |
Pretax Income | 17.38 | -82.26 | -9.05 | 33.7 | 45.55 | 31.3 |
Income Tax Expense | 13.54 | -1.82 | 11.16 | 12.35 | 5.89 | 3.79 |
Net Income | 3.84 | -80.45 | -20.21 | 21.35 | 39.67 | 27.51 |
Net Income to Common | 3.84 | -80.45 | -20.21 | 21.35 | 39.67 | 27.51 |
Net Income Growth | - | - | - | -46.18% | 44.18% | 365.26% |
Shares Outstanding (Basic) | 50 | 50 | 49 | 49 | 48 | 47 |
Shares Outstanding (Diluted) | 50 | 50 | 49 | 49 | 49 | 49 |
Shares Change | 2.37% | 0.90% | -0.61% | 0.10% | -0.15% | 3.13% |
EPS (Basic) | 0.08 | -1.62 | -0.41 | 0.44 | 0.83 | 0.58 |
EPS (Diluted) | 0.08 | -1.62 | -0.41 | 0.43 | 0.80 | 0.56 |
EPS Growth | - | - | - | -46.25% | 42.86% | 366.67% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 3, 2026 | Jan '26 Jan 2, 2026 | Dec '24 Dec 27, 2024 | Dec '23 Dec 29, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -6.75 | -40.05 | -7.67 | -3.59 | 17.61 | 30.32 |
Free Cash Flow Per Share | -0.13 | -0.81 | -0.16 | -0.07 | 0.36 | 0.61 |
Gross Margin | 76.62% | 76.19% | 76.32% | 78.36% | 78.55% | 77.51% |
Operating Margin | 12.15% | -19.10% | -3.93% | 9.21% | 15.58% | 14.42% |
Profit Margin | 1.13% | -33.60% | -6.44% | 6.62% | 13.95% | 11.94% |
Free Cash Flow Margin | -1.99% | -16.73% | -2.44% | -1.11% | 6.19% | 13.15% |
EBITDA | 49.76 | -37.42 | -5.46 | 34.83 | 48.81 | 36.88 |
EBITDA Margin | 14.65% | -15.63% | -1.74% | 10.80% | 17.16% | 16.00% |
D&A For EBITDA | 8.5 | 8.32 | 6.89 | 5.12 | 4.51 | 3.64 |
EBIT | 41.26 | -45.74 | -12.35 | 29.71 | 44.3 | 33.24 |
EBIT Margin | 12.15% | -19.10% | -3.93% | 9.21% | 15.58% | 14.42% |
Effective Tax Rate | 77.91% | - | - | 36.65% | 12.92% | 12.12% |
Advertising Expenses | - | 19.63 | 34.08 | 46.68 | 37.92 | 21.99 |